Rockwell Medical (RMTI) Non-Current Assets (2010 - 2026)
Rockwell Medical's (RMTI) quarterly Non-Current Assets came in at $20.5 million in Q1 2026, down 2.14% YoY from $20.9 million in Q1 2025, and up 7.89% on a QoQ basis from $19.0 million in Q4 2025.
Rockwell Medical (RMTI) Non-Current Assets (2010 - 2026) Analysis & Trends
Rockwell Medical (RMTI) has 17 years of Non-Current Assets data on file, last reported at $20.5 million in Q1 2026.
- Quarterly Non-Current Assets fell 2.14% year-over-year to $20.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $80.4 million (down 9.86% YoY) and the FY2025 annual result came in at $19.0 million, down 14.41% from the prior year.
- Non-Current Assets advanced to $20.5 million in Q1 2026, from $19.0 million in the prior quarter.
- In the past five years, Non-Current Assets ranged from a high of $24.4 million in Q3 2023 to a low of $10.5 million in Q2 2023.
- A 5-year average of $18.3 million and a median of $20.5 million in 2026 frame the typical range for Non-Current Assets.
- Annual changes were most pronounced in 2022 — Non-Current Assets dropped 14.76% — and 2024, when it surged 122.84%.
- Tracing RMTI's Non-Current Assets over 5 years: stood at $11.3 million in 2022, then soared by 106.65% to $23.4 million in 2023, then decreased by 5.23% to $22.2 million in 2024, then declined by 14.41% to $19.0 million in 2025, then grew by 7.89% to $20.5 million in 2026.
- The last three Non-Current Assets figures came in at $20.5 million (Q1 2026), $19.0 million (Q4 2025), and $20.0 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.31 Bn | 43.35 Bn | - | 37.96 Bn |
| 2 | Teva Pharmaceutical Industries | 43.86 Bn | 40.20 Bn | 2.15 Bn | 26.10 Bn |
| 3 | Zoetis | 32.13 Bn | 30.45 Bn | 1.05 Bn | 8.72 Bn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.84 Bn | 5.10 Bn | 78.51 Bn |
| 5 | United Therapeutics | 22.22 Bn | 19.56 Bn | 683.80 Mn | 3.74 Bn |
| 6 | Viatris | 18.82 Bn | 17.93 Bn | 1.46 Bn | 24.99 Bn |
| 7 | Neurocrine Biosciences | 15.48 Bn | 15.09 Bn | 935.80 Mn | 3.72 Bn |
| 8 | Elanco Animal Health | 12.00 Bn | 11.47 Bn | 798.00 Mn | 9.76 Bn |
| 9 | Dr Reddys Laboratories | 10.08 Bn | 9.92 Bn | - | 2.96 Bn |
| 10 | Rockwell Medical | 30.22 Mn | 5.43 Mn | 3.24 Mn | 20.17 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 20.17 Mn |
| Mar 31, 2026 | 20.48 Mn |
| Dec 31, 2025 | 18.98 Mn |
| Sep 30, 2025 | 19.97 Mn |
| Jun 30, 2025 | 21.02 Mn |
| Mar 31, 2025 | 20.93 Mn |
| Dec 31, 2024 | 22.18 Mn |
| Sep 30, 2024 | 22.87 Mn |
| Jun 30, 2024 | 23.28 Mn |
| Mar 31, 2024 | 24.03 Mn |
| Dec 31, 2023 | 23.40 Mn |
| Sep 30, 2023 | 24.43 Mn |
| Jun 30, 2023 | 10.47 Mn |
| Mar 31, 2023 | 10.78 Mn |
| Dec 31, 2022 | 11.33 Mn |
| Sep 30, 2022 | 11.83 Mn |
| Jun 30, 2022 | 11.87 Mn |
| Mar 31, 2022 | 12.64 Mn |
| Dec 31, 2021 | 13.29 Mn |
| Sep 30, 2021 | 12.62 Mn |